Proposed monographs for omission from the BP 2019
The BP is intending to omit the following three monographs from the BP 2019 edition:
Prolonged-release Salbutamol Tablets
These monographs have been proposed for omission due to the lack of UK based Marketing Authorisation Holders and low usage within the UK.
To ensure that adequate consultation is undertaken with our stakeholders, you are invited to provide feedback on whether the above monographs should be omitted from the BP 2019. Input from our stakeholders at this stage is important so that the use of these monographs internationally can be taken into account prior to publication.
The deadline for responses is the 12th March 2018.